Skip to content
PIL Logo

Femoston 1/10mg and 2/10mg

Last Updated on eMC 22-Nov-2016 View document  | Mylan Products Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22-Nov-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 3 - how to take/use

Updated on 10-Nov-2016 and displayed until 22-Nov-2016

Reasons for adding or updating:

  • Change to section 6 - what the product contains

Updated on 26-Aug-2016 and displayed until 10-Nov-2016

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder

Updated on 11-May-2016 and displayed until 26-Aug-2016

Reasons for adding or updating:

  • Improved presentation of PIL

Updated on 27-Apr-2016 and displayed until 11-May-2016

Reasons for adding or updating:

  • Change to section 5 - how to store

Updated on 19-Apr-2016 and displayed until 27-Apr-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 23-Feb-2016 and displayed until 19-Apr-2016

Reasons for adding or updating:

  • Change to other sources of information section

Updated on 22-Apr-2015 and displayed until 23-Feb-2016

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
  • Company name change or merger

Updated on 24-Mar-2015 and displayed until 22-Apr-2015

Reasons for adding or updating:

  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 16-Oct-2014 and displayed until 24-Mar-2015

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects

Updated on 02-Oct-2014 and displayed until 16-Oct-2014

Reasons for adding or updating:

  • Change to section 1 - what the product is used for

Updated on 15-Aug-2014 and displayed until 02-Oct-2014

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder

Updated on 05-Mar-2012 and displayed until 15-Aug-2014

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 24-Feb-2011 and displayed until 05-Mar-2012

Reasons for adding or updating:

  • Change to date of revision
  • Company name change or merger

Updated on 26-Nov-2009 and displayed until 24-Feb-2011

Reasons for adding or updating:

  • Extra statutory information
  • Change to name of manufacturer

Updated on 26-Nov-2009 and displayed until 26-Nov-2009

Reasons for adding or updating:

  • Change of manufacturer
  • Extra statutory information

Updated on 24-Apr-2008 and displayed until 26-Nov-2009

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 05-Mar-2008 and displayed until 24-Apr-2008

Reasons for adding or updating:

  • Change to packaging
  • Change to storage instructions
  • Change to warnings or special precautions for use

Updated on 05-Mar-2008 and displayed until 05-Mar-2008

Reasons for adding or updating:

  • Change to packaging
  • Change to storage instructions

Updated on 17-Jan-2006 and displayed until 05-Mar-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision

Updated on 25-Jul-2001 and displayed until 17-Jan-2006

Reasons for adding or updating:

  • Update to PIL

Updated on 13-Mar-2001 and displayed until 25-Jul-2001

Reasons for adding or updating:

  • No reasons supplied

Updated on 13-Mar-2000 and displayed until 13-Mar-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Mylan Products Limited

Company image
Address

20 Station Close, Potters Bar, Hertfordshire, EN6 1TL, UK

Medical Information Direct Line

+44 (0)1707 853000

Telephone

+44 (0)1707 853 000

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

dydrogesterone, estradiol hemihydrate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue